<DOC>
	<DOCNO>NCT02141711</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics TAK-438 healthy , non-Japanese men male subject follow randomize , double blind , placebo control , sequential panel , multiple-dose schedule .</brief_summary>
	<brief_title>TAK-438 - Safety , Blood Levels &amp; Effects Repeated Doses</brief_title>
	<detailed_description>The drug test study call TAK-438 . TAK-438 test find safe well-tolerated dose . This study look pharmacokinetic ( effect body drug ) pharmacodynamic property ( effect drug body ) well look lab result side effect people take TAK-438 . This study design randomize , sequential-panel , multiple repeat dose study . The study population consist 4 Cohorts 12 participant Cohort ; 9 participant randomize receive single dose TAK-438 , 3 participant receive placebo . Participants Cohort receive single dose study drug daily 10-hour fast . The start dose 10 mg follow administration 20 , 40 , 30 mg . This single-centre trial conduct United Kingdom . The overall time participate study 37 day . Participants make 2 visit clinic screening , one 11-day period confinement clinic , 2 visit confinement period . All participant contact telephone 7 day last dose study drug follow-up assessment .</detailed_description>
	<mesh_term>Gastroesophageal Reflux</mesh_term>
	<mesh_term>Esophagitis</mesh_term>
	<criteria>Male subject age 18 45 , inclusive , good health , determine medical history , physical examination , clinical laboratory evaluation urine drug screen . The subject ability tolerate pH probe 24 hour prior Randomization ( Day 1 ) . Clinically significant history hypersensitivity drug food excipients TAK438 History gastroesophageal reflux disease ( GERD ) , symptomatic GERD , erosive esophagitis , duodenal ulcer , gastric ulcer , dyspepsia , Barrett 's esophagus , ZollingerEllison syndrome The subject positive test result Helicobacter pylorus Initial Screening Visit Any clinically significant result physical examination clinical laboratory result deem investigator .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Drug therapy</keyword>
</DOC>